Evidence map›Paper›PMID 29135333›Full record

ArticleRNA biology2018

Challenges of ligand identification for the second wave of orphan riboswitch candidates.

Etienne B Greenlee, Shira Stav, Ruben M Atilho, Kenneth I Brewer, Kimberly A Harris, Sarah N Malkowski, Gayan Mirihana Arachchilage, Kevin R Perkins, Madeline E Sherlock, Ronald R Breaker

Open access · bronzeAbstract read
In one paragraph

Article in RNA biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. ACS chemical biology · 2025
    Article
  3. The current riboswitch landscape inMicrobiology (Reading, England) · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Discovering riboswitches: the past and the future.Trends in biochemical sciences · 2023
    Review
  8. Variants of the guanine riboswitch class exhibit altered ligand specificities for xanthine, guanine, or 2'-deoxyguanosine.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. RNA Engineering for Public Health: Innovations in RNA-Based Diagnostics and Therapeutics.Annual review of chemical and biomolecular engineering · 2021
    Article
  15. A translational riboswitch coordinates nascent transcription-translation coupling.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Etienne B Greenleea Department of Molecular , Cellular and Developmental Biology, Yale University , New Haven , CT , USA.
Shira Stava Department of Molecular , Cellular and Developmental Biology, Yale University , New Haven , CT , USA.
Ruben M Atilhob Department of Molecular Biophysics and Biochemistry , Yale University , New Haven , CT , USA.
Kenneth I Brewerb Department of Molecular Biophysics and Biochemistry , Yale University , New Haven , CT , USA.
Kimberly A Harrisa Department of Molecular , Cellular and Developmental Biology, Yale University , New Haven , CT , USA.ORCID 0000-0003-3028-5863
Sarah N Malkowskic Department of Chemistry , Yale University , New Haven , CT , USA.ORCID 0000-0002-9644-6917
Gayan Mirihana Arachchilaged Howard Hughes Medical Institute, Yale University , New Haven , CT , USA.
Kevin R Perkinsa Department of Molecular , Cellular and Developmental Biology, Yale University , New Haven , CT , USA.
Madeline E Sherlockb Department of Molecular Biophysics and Biochemistry , Yale University , New Haven , CT , USA.ORCID 0000-0002-6471-4243
Ronald R Breakera Department of Molecular , Cellular and Developmental Biology, Yale University , New Haven , CT , USA.ORCID 0000-0002-2165-536X
Yale University · USHoward Hughes Medical Institute · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
X-RAY ANALYSIS OF PROTEIN STRUCTURE AND FUNCTIONP01GM022778 · NIGMS · YALE UNIVERSITY · PI BREAKER, RONALD R · 1985 to 2019
$26.1M
Translational CoreP01DK057751 · NIDDK · YALE UNIVERSITY · PI YANG, XIAOYONG · 2001 to 2020
$25.6M
Investigating Mechanisms of Fluoride Sensing and Toxicity Mitigation in BacteriaR01DE022340 · NIDCR · YALE UNIVERSITY · PI BREAKER, RONALD R · 2012 to 2015
$1.5M
Establishing the Function of an Exceptional Bacterial Noncoding RNAF32GM116426 · NIGMS · YALE UNIVERSITY · PI HARRIS, KIMBERLY A · 2015 to 2016
$112k
NIDCR NIH HHS R01 DE022340NIGMS NIH HHS F32 GM116426NIGMS NIH HHS P01 GM022778NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

Orphan riboswitch candidates are noncoding RNA motifs whose representatives are believed to function as genetic regulatory elements, but whose target ligands have yet to be identified. The study of certain orphans, particularly classes that have resisted experimental validation for many years, has led to the discovery of important biological pathways and processes once their ligands were identified. Previously, we highlighted details for four of the most common and intriguing orphan riboswitch candidates. This facilitated the validation of riboswitches for the signaling molecules c-di-AMP, ZTP, and ppGpp, the metal ion Mn

Indexed as

RiboswitchAmino Acid MotifsAptamers, NucleotideBacteriaLigandsModels, MolecularNucleic Acid ConformationRNA, BacterialRNA, FungalRNA, MessengerYeastsAptamers, NucleotideLigandsRiboswitchRNA, BacterialRNA, FungalRNA, MessengerAptamercomparative sequence analysisgene regulationmetabolitenoncoding RNAsignaling molecule

Identifiers

PMID29135333
PMCPMC5927730
OpenAlexW2769114003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.